[
    {
        "id": "-3949122174215150978",
        "title": "Global pharma stocks down as Trump renews tariff threat | $PPH $JNJ $PFE $MRK $GILD",
        "url": "https://seekingalpha.com/news/4458764-pharma-stocks-down-trump-renews-tariff-threat",
        "site": "seekingalpha.com",
        "time": 1750158955000,
        "favicon_url": "https://static.tickertick.com/website_icons/seekingalpha.com.ico",
        "tags": [
            "gild"
        ],
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "-8482368098352016216",
        "title": "Sens. Sanders, King introduce bill to end prescription drug advertising | $GILD $GSK $BMY $PFE $NVO",
        "url": "https://seekingalpha.com/news/4457730-sens-sanders-king-introduce-bill-end-prescription-drug-advertising",
        "site": "seekingalpha.com",
        "time": 1749751357000,
        "favicon_url": "https://static.tickertick.com/website_icons/seekingalpha.com.ico",
        "tags": [
            "gild"
        ],
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "5623473636889574647",
        "title": "Gilead faces clinical hold on trials of two HIV candidates | $GILD",
        "url": "https://seekingalpha.com/news/4456926-gilead-faces-clinical-hold-trials-two-hiv-candidates",
        "site": "seekingalpha.com",
        "time": 1749567010000,
        "favicon_url": "https://static.tickertick.com/website_icons/seekingalpha.com.ico",
        "tags": [
            "gild"
        ],
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "1070604878014882191",
        "title": "FDA Pauses Trials of Gilead HIV Combination After Safety Signal",
        "url": "https://www.bloomberg.com/news/articles/2025-06-10/fda-pauses-trials-of-gilead-hiv-combination-after-safety-signal",
        "site": "bloomberg.com",
        "time": 1749565090000,
        "favicon_url": "https://static.tickertick.com/website_icons/bloomberg.com.ico",
        "tags": [
            "gild"
        ],
        "similar_stories": [
            "272429011078618108"
        ],
        "description": "Gilead Sciences Inc. said federal regulators had placed on hold trials of a new experimental once-weekly HIV drug combination therapy after white blood cell counts dropped in some of the patients. Scott McCauley, associate scientist at the Gilead Sciences Inc., makes human proteins at the Gilead laboratory in Foster City, California, U.S., on Wednesday, Aug. 10, 2011. Gilead Sciences Inc., the world's biggest maker of AIDS drugs, is re-entering the market for cancer medicines a decade after selling its oncology unit. Photographer: David Paul Morris",
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "-6172354036462676875",
        "title": "Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO",
        "url": "https://www.cnbc.com/2025/06/03/healthy-returns-astrazeneca-pfizer-gilead-release-cancer-drug-data.html",
        "site": "cnbc.com",
        "time": 1748979265000,
        "favicon_url": "https://static.tickertick.com/website_icons/cnbc.com.ico",
        "tags": [
            "gild"
        ],
        "description": "Drugmakers unveil cancer drug data at the ASCO annual meeting, while Amazon Pharmacy announces new features for caregivers, Medicare patients.",
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "-3424939157817647363",
        "title": "Gilead’s Trodelvy with Merck’s Keytruda cuts disease progression/ death in breast cancer",
        "url": "https://seekingalpha.com/news/4454037-gileads-trodelvy-keytruda-cuts-breast-cancer-risk",
        "site": "seekingalpha.com",
        "time": 1748697160000,
        "favicon_url": "https://static.tickertick.com/website_icons/seekingalpha.com.ico",
        "tags": [
            "gild"
        ],
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "-8526857608518183177",
        "title": "Gilead succeeds in late-stage trial for breast cancer therapy Trodelvy as a first line option | $GILD",
        "url": "https://seekingalpha.com/news/4452013-gilead-posts-trial-win-trodelvy-breast-cancer",
        "site": "seekingalpha.com",
        "time": 1748005662000,
        "favicon_url": "https://static.tickertick.com/website_icons/seekingalpha.com.ico",
        "tags": [
            "gild"
        ],
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "-7409697670557558172",
        "title": "Trump threatens to limit imports if countries don't pay more for drugs | $AMGN $GILD $VRTX $JNJ $GSK",
        "url": "https://seekingalpha.com/news/4451889-trump-threatens-limit-imports-if-countries-dont-pay-more-drugs",
        "site": "seekingalpha.com",
        "time": 1747951661000,
        "favicon_url": "https://static.tickertick.com/website_icons/seekingalpha.com.ico",
        "tags": [
            "gild"
        ],
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "1955993118661456512",
        "title": "Gilead to buy certain Hookipa Pharma assets for up to $10M | $GILD $HOOK",
        "url": "https://seekingalpha.com/news/4451640-hookipa-stock-gains-gilead-eyes-assets",
        "site": "seekingalpha.com",
        "time": 1747924902000,
        "favicon_url": "https://static.tickertick.com/website_icons/seekingalpha.com.ico",
        "tags": [
            "gild"
        ],
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "-611165736927414161",
        "title": "Sanofi will invest at least $20B in the U.S., focus on R&D spends | $SNY $GILD $JNJ $LLY",
        "url": "https://seekingalpha.com/news/4448146-sanofi-will-invest-at-least-20b-in-the-us-focus-on-rd-spends",
        "site": "seekingalpha.com",
        "time": 1747242035000,
        "favicon_url": "https://static.tickertick.com/website_icons/seekingalpha.com.ico",
        "tags": [
            "gild"
        ],
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "8754954249369292258",
        "title": "Roche plans $700M North Carolina facility | $RHHBY $GILD $JNJ $LLY",
        "url": "https://seekingalpha.com/news/4446479-roche-plans-700m-north-carolina-facility",
        "site": "seekingalpha.com",
        "time": 1747061591000,
        "favicon_url": "https://static.tickertick.com/website_icons/seekingalpha.com.ico",
        "tags": [
            "gild"
        ],
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "2365901275799788361",
        "title": "Merck boosts U.S. investments with $895M expansion in Kansas site | $MRK $GILD $JNJ $LLY",
        "url": "https://seekingalpha.com/news/4444575-merck-announces-895m-expansion-kansas-site",
        "site": "seekingalpha.com",
        "time": 1746711772000,
        "favicon_url": "https://static.tickertick.com/website_icons/seekingalpha.com.ico",
        "tags": [
            "gild"
        ],
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "-8761993409895210421",
        "title": "Gilead to invest about $32B in U.S. manufacturing through 2030 | $GILD $JNJ $LLY",
        "url": "https://seekingalpha.com/news/4443572-gilead-to-invest-about-32b-in-us-manufacturing-through-2030",
        "site": "seekingalpha.com",
        "time": 1746645250000,
        "favicon_url": "https://static.tickertick.com/website_icons/seekingalpha.com.ico",
        "tags": [
            "gild"
        ],
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "-4434829733879358755",
        "title": "Notable healthcare headlines for the week: Gilead, CVS Health, Sanofi in focus",
        "url": "https://seekingalpha.com/news/4440733-notable-healthcare-headlines-for-the-week-gilead-cvs-health-sanofi-in-focus",
        "site": "seekingalpha.com",
        "time": 1746384837000,
        "favicon_url": "https://static.tickertick.com/website_icons/seekingalpha.com.ico",
        "tags": [
            "gild"
        ],
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "-2486077376784900768",
        "title": "Gilead and Vertex Pharma named among biotech’s tariff safe havens",
        "url": "https://seekingalpha.com/news/4440688-gilead-vertex-among-biotechs-tariff-havens",
        "site": "seekingalpha.com",
        "time": 1746295795000,
        "favicon_url": "https://static.tickertick.com/website_icons/seekingalpha.com.ico",
        "tags": [
            "gild"
        ],
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "5800546691035324531",
        "title": "Gilead in $202M settlement with DoJ over kickbacks to doctors",
        "url": "https://seekingalpha.com/news/4437229-gilead-202m-settlement-doj-kickbacks-doctors",
        "site": "seekingalpha.com",
        "time": 1745951811000,
        "favicon_url": "https://static.tickertick.com/website_icons/seekingalpha.com.ico",
        "tags": [
            "gild"
        ],
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "-6992764689862886939",
        "title": "Gilead Reaches $202 Million Settlement Over Payments to Doctors",
        "url": "https://www.bloomberg.com/news/articles/2025-04-29/gilead-sciences-agrees-to-pay-202-million-over-doctor-payments",
        "site": "bloomberg.com",
        "time": 1745950227000,
        "favicon_url": "https://static.tickertick.com/website_icons/bloomberg.com.ico",
        "tags": [
            "gild"
        ],
        "similar_stories": [
            "5800546691035324531"
        ],
        "description": "Gilead Sciences Inc. reached a $202 settlement with the US to resolve claims that it paid doctors and gave them meals and travel expenses for events to get them to prescribe its drugs. Gilead Sciences headquarters in Foster City, California.",
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "3436708158354947122",
        "title": "Gilead Sciences agrees to pay $202 million to settle claims of kickbacks to doctors for HIV drug prescriptions",
        "url": "https://www.cnbc.com/2025/04/29/gilead-sciences-agrees-to-pay-202-million-to-settle-claims-of-kickbacks-to-doctors-for-hiv-drug-prescriptions.html",
        "site": "cnbc.com",
        "time": 1745948899000,
        "favicon_url": "https://static.tickertick.com/website_icons/cnbc.com.ico",
        "tags": [
            "gild"
        ],
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "4160327020069999296",
        "title": "SA analyst downgrades: TSLA, AAPL, T, PG, HPE, GILD, LRCX, ARCC | $AAPL $T $PG $GILD $LRCX",
        "url": "https://seekingalpha.com/news/4436428-sa-analyst-downgrades-tsla-aapl-t-pg-hpe-gild-lrcx-arcc",
        "site": "seekingalpha.com",
        "time": 1745864792000,
        "favicon_url": "https://static.tickertick.com/website_icons/seekingalpha.com.ico",
        "tags": [
            "gild"
        ],
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "568454600217905390",
        "title": "Daily Dividend Report: OKE, Charles Schwab, Gilead, Sysco, PH",
        "url": "https://www.forbes.com/sites/dividendchannel/2025/04/28/daily-dividend-report-oke-charles-schwab-gilead-sysco-ph/",
        "site": "forbes.com",
        "time": 1745863690000,
        "favicon_url": "https://static.tickertick.com/website_icons/forbes.com.ico",
        "tags": [
            "gild"
        ],
        "description": "Daily Dividend Report: OKE, Charles Schwab, Gilead, Sysco, PH Daily Dividend Report: OKE, Charles Schwab, Gilead, Sysco, PH",
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "1298091845830554588",
        "title": "No misses here: Healthcare earnings sweep past Wall Street estimates | $XLV $AMGN $GILD $BMY $CVS",
        "url": "https://seekingalpha.com/news/4435756-no-misses-here-healthcare-earnings-sweep-past-wall-street-estimates",
        "site": "seekingalpha.com",
        "time": 1745769300000,
        "favicon_url": "https://static.tickertick.com/website_icons/seekingalpha.com.ico",
        "tags": [
            "gild"
        ],
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "-8024263238642621866",
        "title": "4 stocks to watch on Friday: GILD, ABBV, CL and SLB | $GILD $CL $SLB $ABBV",
        "url": "https://seekingalpha.com/news/4435589-4-stocks-to-watch-on-friday-gild-abbv-cl-and-slb",
        "site": "seekingalpha.com",
        "time": 1745587673000,
        "favicon_url": "https://static.tickertick.com/website_icons/seekingalpha.com.ico",
        "tags": [
            "gild"
        ],
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "4980293298678019386",
        "title": "Gilead Sciences declares $0.79 dividend | $GILD",
        "url": "https://seekingalpha.com/news/4435442-gilead-sciences-declares-0_79-dividend",
        "site": "seekingalpha.com",
        "time": 1745561748000,
        "favicon_url": "https://static.tickertick.com/website_icons/seekingalpha.com.ico",
        "tags": [
            "gild"
        ],
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "1568250421105432958",
        "title": "Gilead sciences highlights potential FDA approval for lenacapavir in June 2025",
        "url": "https://seekingalpha.com/news/4435389-gilead-sciences-highlights-potential-fda-approval-for-lenacapavir-in-june-2025",
        "site": "seekingalpha.com",
        "time": 1745539375000,
        "favicon_url": "https://static.tickertick.com/website_icons/seekingalpha.com.ico",
        "tags": [
            "gild"
        ],
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "-6064122460091354080",
        "title": "Gilead down 3% after hours as 2025 diluted EPS guidance lowered",
        "url": "https://seekingalpha.com/news/4435362-gilead-down-3-percent-after-hours-2025-diluted-eps-guidance-lowered",
        "site": "seekingalpha.com",
        "time": 1745530483000,
        "favicon_url": "https://static.tickertick.com/website_icons/seekingalpha.com.ico",
        "tags": [
            "gild"
        ],
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "9219474983766705674",
        "title": "Gilead Sciences in charts: Revenue from HIV product sales grows most among segments in Q1",
        "url": "https://seekingalpha.com/news/4435351-gilead-sciences-in-charts-revenue-from-hiv-product-sales-grows-most-among-segments-in-q1",
        "site": "seekingalpha.com",
        "time": 1745529381000,
        "favicon_url": "https://static.tickertick.com/website_icons/seekingalpha.com.ico",
        "tags": [
            "gild"
        ],
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "-7205552780883830432",
        "title": "Gilead Sciences Non-GAAP EPS of $1.81 beats by $0.04, revenue of $6.67B misses by $140M",
        "url": "https://seekingalpha.com/news/4435218-gilead-sciences-non-gaap-eps-of-1_81-beats-by-0_04-revenue-of-6_67b-misses-by-140m",
        "site": "seekingalpha.com",
        "time": 1745525023000,
        "favicon_url": "https://static.tickertick.com/website_icons/seekingalpha.com.ico",
        "tags": [
            "gild"
        ],
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "-8354475128386887087",
        "title": "Gilead Sciences Q1 2025 Earnings Preview | $GILD",
        "url": "https://seekingalpha.com/news/4434076-gilead-sciences-q1-2025-earnings-preview",
        "site": "seekingalpha.com",
        "time": 1745420909000,
        "favicon_url": "https://static.tickertick.com/website_icons/seekingalpha.com.ico",
        "tags": [
            "gild"
        ],
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "7658467591472038013",
        "title": "Gilead Trodelvy + Merck Keytruda combo excels in first-line breast cancer | $GILD $MRK",
        "url": "https://seekingalpha.com/news/4432729-gilead-trodelvy-merck-keytruda-combo-excels-first-line-breast-cancer",
        "site": "seekingalpha.com",
        "time": 1745241986000,
        "favicon_url": "https://static.tickertick.com/website_icons/seekingalpha.com.ico",
        "tags": [
            "gild"
        ],
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "3497366762140739594",
        "title": "Nurix gets FDA clearance to initiate trial for its anti-inflammatory drug candidate | $GILD $NRIX",
        "url": "https://seekingalpha.com/news/4432156-nurix-gets-fda-clearance-to-initiate-trial-for-its-anti-inflammatory-drug-candidate",
        "site": "seekingalpha.com",
        "time": 1744897237000,
        "favicon_url": "https://static.tickertick.com/website_icons/seekingalpha.com.ico",
        "tags": [
            "gild"
        ],
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "6424699567489072145",
        "title": "Senior leaders at HHS put on administrative leave amid staff cuts - report | $AMGN $GILD $JNJ $BMY $PFE",
        "url": "https://seekingalpha.com/news/4427589-senior-leaders-hhs-put-administrative-leave-amid-staff-cuts",
        "site": "seekingalpha.com",
        "time": 1743522337000,
        "favicon_url": "https://static.tickertick.com/website_icons/seekingalpha.com.ico",
        "tags": [
            "gild"
        ],
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "-544963840250807860",
        "title": "CVS, COR, among top S&P 500 healthcare gainers in Q1; WST and MRNA among losers | $XLV $GILD $VRTX $CVS $CI",
        "url": "https://seekingalpha.com/news/4426755-cvs-cor-among-top-sp-500-healthcare-gainers-in-q1-wst-and-mrna-among-losers",
        "site": "seekingalpha.com",
        "time": 1743519535000,
        "favicon_url": "https://static.tickertick.com/website_icons/seekingalpha.com.ico",
        "tags": [
            "gild"
        ],
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "7406886393570327266",
        "title": "Democrats warn Trump about consequences of HIV prevention cuts | $GILD $GSK $PFE $SGIOF $SGIOY",
        "url": "https://seekingalpha.com/news/4423629-democrats-warn-trump-about-hiv-prevention-cuts",
        "site": "seekingalpha.com",
        "time": 1742580853000,
        "favicon_url": "https://static.tickertick.com/website_icons/seekingalpha.com.ico",
        "tags": [
            "gild"
        ],
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "-9177704477810959488",
        "title": "Stock of the Day: Gilead Sciences falls on report the Trump administration could slash funds for HIV prevention",
        "url": "https://markets.businessinsider.com/news/stocks/gilead-sciences-stock-price-biopharma-hiv-prevention-gsk-trump-hhs-2025-3",
        "site": "businessinsider.com",
        "time": 1742388984000,
        "favicon_url": "https://static.tickertick.com/website_icons/businessinsider.com.ico",
        "tags": [
            "gild"
        ],
        "description": "The Health and Human Services Department is considering cuts to HIV prevention funding, according to The Wall Street Journal. Stock of the Day: Gilead Sciences falls on report the Trump administration could slash funds for HIV preventionJohn Moore/Getty ImagesFederal funding for HIV prevention could be slashed, according to The Wall Street Journal.Gilead Sciences fell 2.52% in premarket trading on the news.The company makes medication for treating HIV and AIDS. Other biopharma firms also fell.The move: Gilead Sciences dropped 2.52% in premarket trading, falling to $107.45 per share Wednesday morning. The biopharmaceutical company is up 19.34% for the year.Why: The stock's decline follows a report from The Wall Street Journal that the US Health and Human Services Department is considering drastic cuts to federal funding for HIV prevention in the US. Gilead makes treatments for adults with HIV. Sources told the Journal that the funding cutbacks are part of a broader slash that may soon be announced for the Centers for Disease Control and Prevention, with the Trump administration looking to reorganize the agency.What it means: A reduction to the CDC's HIV budget has implications for drugmakers focused on combating this disease. Aside from Gilead, American depositary shares of GSK fell 2.18% in early trading. The multinational biopharma firm is a majority owner of the HIV-focused company Viiv.Read the original article on Business Insider",
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "5354931099102010711",
        "title": "These Stocks Are Moving the Most Today: Nvidia, Tesla, Autodesk, Gilead Sciences, HealthEquity, General Mills, and More",
        "url": "https://www.barrons.com/articles/stock-market-movers-e21de4c8?siteid=yhoof2&yptr=yahoo",
        "site": "barrons.com",
        "time": 1742381400000,
        "favicon_url": "https://static.tickertick.com/website_icons/barrons.com.ico",
        "tags": [
            "gild"
        ],
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "-8121332771196439173",
        "title": "Stocks to Watch Wednesday: Tesla, Nvidia, Gilead, GSK",
        "url": "https://www.wsj.com/livecoverage/fed-interest-rate-decision-inflation-live-03-19-2025/card/stocks-to-watch-wednesday-tesla-nvidia-tencent-general-mills-2ak9uBUBQESDbhd1WS23?siteid=yhoof2&yptr=yahoo",
        "site": "wsj.com",
        "time": 1742381352000,
        "favicon_url": "https://static.tickertick.com/website_icons/wsj.com.ico",
        "tags": [
            "gild"
        ],
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "-5713305602040563970",
        "title": "Gilead, GSK could be impacted by potential HHS HIV prevention cuts | $GILD $JNJ $GSK",
        "url": "https://seekingalpha.com/news/4421969-gilead-gsk-could-impacted-potential-hhs-hiv-prevention-cuts",
        "site": "seekingalpha.com",
        "time": 1742333694000,
        "favicon_url": "https://static.tickertick.com/website_icons/seekingalpha.com.ico",
        "tags": [
            "gild"
        ],
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "4525729022894947979",
        "title": "FDA commissioner nominee Makary advances to full Senate vote | $AMGN $GILD $JNJ $GSK $BMY",
        "url": "https://seekingalpha.com/news/4420365-fda-commissioner-nominee-makary-advances-full-senate-vote",
        "site": "seekingalpha.com",
        "time": 1741877919000,
        "favicon_url": "https://static.tickertick.com/website_icons/seekingalpha.com.ico",
        "tags": [
            "gild"
        ],
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "-1958740625023503020",
        "title": "Merck releases positive phase 3 data on daily oral HIV drug | $MRK $GILD",
        "url": "https://seekingalpha.com/news/4419894-merck-releases-positive-phase-3-data-daily-oral-hiv-drug",
        "site": "seekingalpha.com",
        "time": 1741796472000,
        "favicon_url": "https://static.tickertick.com/website_icons/seekingalpha.com.ico",
        "tags": [
            "gild"
        ],
        "tickers": [
            "gild"
        ]
    },
    {
        "id": "2466859774222483958",
        "title": "Gilead posts early Phase 1 data for once-yearly HIV PrEP therapy",
        "url": "https://seekingalpha.com/news/4419530-gilead-posts-phase-1-data-annual-hiv-prep-drug",
        "site": "seekingalpha.com",
        "time": 1741718214000,
        "favicon_url": "https://static.tickertick.com/website_icons/seekingalpha.com.ico",
        "tags": [
            "gild"
        ],
        "tickers": [
            "gild"
        ]
    }
]